Related Experiment Video
Updated: Jun 3, 2026

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
Glucocorticoid receptor expression and antiproliferative effect of dexamethasone on human melanoma cells
Judit Dobos1, István Kenessey, József Tímár
1Center of Surgical and Molecular Tumor Pathology, National Institute of Oncology, Budapest, Hungary. dobosj76@gmail.com
Abstract:
Glucocorticoids, such as dexamethasone are widely used in cancer therapy and have cell type-specific pro- or antiapoptotic effects. We examined whether melanoma cells are sensitive to dexamethasone treatment. We have demonstrated for the first time that in human melanoma cell lines as well as in benign and malignant melanocytic tumors glucocorticoid receptor (GCR) is present both at mRNA and protein level. Dexamethasone applied at high doses inhibited the in vitro growth of WM983A human melanoma cells. The inhibitory effect was due to apoptosis induction. In the case of this relatively sensitive cell line dexamethasone enhanced the effect of the chemotherapeutic drug DTIC.
Insights
Dexamethasone, a glucocorticoid, induces apoptosis and inhibits growth in human melanoma cells. It also enhances the efficacy of chemotherapy drug DTIC in these cancer cells.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Glucocorticoids like dexamethasone are utilized in cancer treatment.
- These steroids exhibit varied effects on cell death pathways, depending on cell type.
- The impact of dexamethasone on melanoma cells remains incompletely understood.
Purpose of the Study:
- To investigate the sensitivity of human melanoma cells to dexamethasone treatment.
- To determine the presence and role of the glucocorticoid receptor (GCR) in melanoma.
- To evaluate dexamethasone's potential as a sensitizer for chemotherapy in melanoma.
Main Methods:
- Analysis of glucocorticoid receptor (GCR) mRNA and protein expression in melanoma cell lines and tumors.
- In vitro assessment of dexamethasone's effect on WM983A human melanoma cell growth.
- Evaluation of dexamethasone's impact on apoptosis induction.
- Combination studies with dexamethasone and the chemotherapeutic drug DTIC.
Main Results:
- Glucocorticoid receptor (GCR) was detected at both mRNA and protein levels in human melanoma cell lines and tumors.
- High-dose dexamethasone significantly inhibited the in vitro growth of WM983A melanoma cells.
- The growth inhibition was attributed to the induction of apoptosis.
- Dexamethasone potentiated the anti-cancer effect of DTIC in this melanoma cell line.
Conclusions:
- Human melanoma cells express the glucocorticoid receptor (GCR).
- Dexamethasone exhibits anti-proliferative and pro-apoptotic effects on human melanoma cells.
- Dexamethasone may serve as a valuable adjuvant therapy to enhance chemotherapy efficacy in melanoma treatment.
More Related Videos
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024